Sars-Cov-2 Serology Test
QVP is the FDA product code for Sars-Cov-2 Serology Test, a class II device type, regulated under 21 CFR 866.3983. FDA's definition for this code reads: "A SARS-CoV-2 serology test is a prescription in vitro diagnostic device for the detection of specific binding antibodies to SARS-CoV-2 in clinical specimens. The detection of SARS-CoV-2 antibodies is intended to aid in identifying individuals with an adaptive immune response to SARS-CoV-2. The test is not intended for...". As of , FDA records hold 5 510(k) clearances under this code, the most recent dated , and no recalls.
Classification record
- Product code
- QVP
- Device name
- Sars-Cov-2 Serology Test
- FDA definition
- A SARS-CoV-2 serology test is a prescription in vitro diagnostic device for the detection of specific binding antibodies to SARS-CoV-2 in clinical specimens. The detection of SARS-CoV-2 antibodies is intended to aid in identifying individuals with an adaptive immune response to SARS-CoV-2. The test is not intended for the diagnosis of acute SARS-CoV-2 infection, nor screening blood, plasma, cells, or tissue donors.
- Regulation
- 21 CFR 866.3983
- Device class
- Class II
- Review panel
- Microbiology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 5
- Ingested recalls
- 0
Clearances, product code QVP
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 2023 | 2 |
| 2025 | 2 |
| 2026 | 1 |
Applicants with the most clearances
Product code QVP| Applicant | Clearances |
|---|---|
| Roche Diagnostics GmbH | 3 |
| Ortho-Clinical Diagnostics, Inc. | 2 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
